4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000027
CEO bought 40,000 shares at an average $0.01 ($596)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
9 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-04-26 | Purchase : show line 1 in the form | +2,000 | $0.01 | $30 | 21,120,123 | D |
| 2019-04-26 | Purchase : show line 2 in the form | +5,000 | $0.01 | $74 | 21,125,123 | D |
| 2019-04-26 | Purchase : show line 3 in the form | +10,000 | $0.01 | $147 | 21,135,123 | D |
| 2019-04-26 | Purchase : show line 4 in the form | +10,000 | $0.01 | $148 | 21,145,123 | D |
| 2019-04-26 | Purchase : show line 5 in the form | +2,000 | $0.02 | $31 | 21,147,123 | D |
| 2019-04-26 | Purchase : show line 6 in the form | +5,000 | $0.01 | $74 | 21,152,123 | D |
| 2019-04-29 | Purchase : show line 7 in the form | +2,000 | $0.02 | $32 | 21,154,123 | D |
| 2019-04-29 | Purchase : show line 8 in the form | +2,000 | $0.02 | $32 | 21,156,123 | D |
| 2019-04-29 | Purchase : show line 9 in the form | +2,000 | $0.01 | $30 | 21,158,123 | D |
| Open-market purchases · 40,000 sh · avg $0.01 · $596 | ||||||
Loading xslF345X03/primary_doc.xml…